Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ

Vaccines, DNA

  • VACCINE RESEARCH
    Improved Immunogenicity of a Vaccination Regimen Combining a DNA Vaccine Encoding Brucella melitensis Outer Membrane Protein 31 (Omp31) and Recombinant Omp31 Boosting
    Juliana Cassataro, Carlos A. Velikovsky, Laura Bruno, Silvia M. Estein, Silvia de la Barrera, Raúl Bowden, Carlos A. Fossati, Guillermo H. Giambartolomei
  • VETERINARY IMMUNOLOGY
    Limited Protection Conferred by a DNA Vaccine against a Lethal Pseudorabies Virus Infection at Day 5 Postvaccination
    Daniel Dory, Anne-Marie Torché, Véronique Béven, Roland Cariolet, André Jestin
  • VACCINE RESEARCH
    DNA Vaccine Construct Incorporating Intercellular Trafficking and Intracellular Targeting Motifs Effectively Primes and Induces Memory B- and T-Cell Responses in Outbred Animals
    Waithaka Mwangi, Wendy C. Brown, Gary A. Splitter, Christopher J. Davies, Chris J. Howard, Jayne C. Hope, Yoko Aida, Yan Zhuang, Beverly J. Hunter, Guy H. Palmer
  • VACCINE RESEARCH
    A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical Trial
    Julie E. Martin, Nancy J. Sullivan, Mary E. Enama, Ingelise J. Gordon, Mario Roederer, Richard A. Koup, Robert T. Bailer, Bimal K. Chakrabarti, Michael A. Bailey, Phillip L. Gomez, Charla A. Andrews, Zoe Moodie, Lin Gu, Judith A. Stein, Gary J. Nabel, Barney S. Graham, the VRC 204 Study Team‡The VRC 204 Study Team includes Margaret M. McCluskey, Brenda Larkin, Sarah Hubka, Lasonji Holman, Laura Novik, Pamela Edmonds, Steve Rucker, Michael Scott, Colleen Thomas, LaChonne Stanford, Ed Tramont, Woody Dubois, Tiffany Alley, Erica Eaton, Sandra Sitar, Ericka Thompson, Andrew Catanzaro, Joseph Casazza, Janie Parrino, Laurence Lemiale, Rebecca Sheets, Ellen Turk, Laurie Lamoreaux, Jennifer Fischer, Mara Abashian, John Rathmann, and Adrienne McNeil.
  • VACCINE RESEARCH
    Distinct Contributions of Vaccine-Induced Immunoglobulin G1 (IgG1) and IgG2a Antibodies to Protective Immunity against Influenza
    Victor C. Huber, Raelene M. McKeon, Martha N. Brackin, Laura A. Miller, Rachael Keating, Scott A. Brown, Natalia Makarova, Daniel R. Perez, Gene H. MacDonald, Jonathan A. McCullers
  • VACCINE RESEARCH
    DNA Vaccine Using Mycobacterium bovis Ag85B Antigen Induces Partial Protection against Experimental Infection in BALB/c Mice
    Francisco M. Teixeira, Henrique C. Teixeira, Ana Paula Ferreira, Michele F. Rodrigues, Vasco Azevedo, Gilson C. Macedo, Sergio C. Oliveira
  • VACCINE RESEARCH
    Immunotargeting with CD154 (CD40 Ligand) Enhances DNA Vaccine Responses in Ducks
    Sheryl L. Gares, Karl P. Fischer, Stephen E. Congly, Stacey Lacoste, William R. Addison, D. Lorne Tyrrell, Klaus S. Gutfreund
  • VACCINE RESEARCH
    Different Levels of Immunogenicity of Two Strains of Fowlpox Virus as Recombinant Vaccine Vectors Eliciting T-Cell Responses in Heterologous Prime-Boost Vaccination Strategies
    Matthew G. Cottingham, Andre van Maurik, Manola Zago, Angela T. Newton, Richard J. Anderson, M. Keith Howard, Jörg Schneider, Michael A. Skinner
  • VACCINE RESEARCH
    Development and Application of Reference Antisera against 15 Hemagglutinin Subtypes of Influenza Virus by DNA Vaccination of Chickens
    Chang-Won Lee, Dennis A. Senne, David L. Suarez

Pages

  • Previous
  • 1
  • 2
  • 3
Back to top

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X